Gene Query: PLXNB1

Dataset Description Geneva Score
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 54.42
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 54.42
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 48.6
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 42.34
Differential analysis of gene regulation at transcript resolution by RNA-Seq 42.34
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 42.1
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 41.42
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 41.42
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 38.89
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 38.75
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 38.75
G-quadruplex structures mark human regulatory chromatin 37.67
Fbxo32 mediated gene expression program underlies EMT and metastasis 36.64
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 36.62
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 36.03
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 35.54
DJ-1 is dispensable for human stem cell homeostasis 33.13
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 33.13
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 32.25
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 32.25
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 31.79
Recovery and analysis of nascent RNA 31.44
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 31.44
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 31.3
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 31.27
Transcriptional profiling of microglia; current state of the art and future perspectives 31.2
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 30.72
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 29.78
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 29.13
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 29.12
Transcriptional profiling of LS1034 cells treated with tepoxalin 28.89
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 27.18
RNA-seq analysis of AML cells in response to ASLAN003 27.1
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 26.54
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 25.55
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 25.52
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 25.52
RNA-seq analysis of uveal melanoma cells treated with FR900359 25.15
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 24.81
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 23.9
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 23.88
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 23.54
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 23.14
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 22.93
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 22.6
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 22.39
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 22.15
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 22.05
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 21.87
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 21.78
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 21.11
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 20.89
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 20.77
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 20.69
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 20.69
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 20.4
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 20.4
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 20.3
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 20.19
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 20.1
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 19.86
A prostate cancer chromatin interaction map 19.68
circRNA-sequencing 19.32
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 19.24
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 19.22
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 18.92
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 18.82
AMPK signaling for naïve pluripotency [Hs] 18.66
AMPK signaling for naïve pluripotency 18.66
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 18.37
CSL RNA-Seq on HKC and SCC cell lines 18.32
CSL 18.32
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 17.95
Searching for target genes of miR-508/509/506/514 in HCT116 cells 17.92
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 17.68
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 17.61
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 17.4
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 17.08
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 16.88
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 16.7
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 16.5
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 16.44
Primary human trophoblast from term placenta 16.38
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 16.15
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 16.06
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 15.95
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 15.92
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 15.89
Transcriptome analysis of BAP1 knockout and restoration 15.89
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 15.89
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 15.85
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 15.65
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 15.55
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 15.5
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 15.3
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 15.26
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 15.22
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 15.2
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 15.08
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 15.02
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 14.99
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 14.91
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 14.85
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 14.79
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  14.67
Universal alternative splicing of noncoding exons 14.66
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 14.65
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 14.64
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 14.52
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 14.46
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 14.46
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 14.41
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 14.34
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 14.27
Effect of mitochondria deficiency on senescence-associated gene expression 14.24
Random mono-allelic expression in MECP2-mutated cells 14.19
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 14.18
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 14.14
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 14.1
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 14.09
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 14.06
circRNA profile in hypopharyngeal cancer 14.02
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 13.91
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 13.83
RNA sequencing of BT142 and TS603 cell lines 13.81
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 13.81
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 13.62
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 13.54
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 13.53
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 13.39
Crizotinib v. DMSO in SW480 cells 13.33
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 13.18
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 13.17
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 13.16
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 13.11
IDH3a KO RNA-seq 13.09
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 13.04
High level DNA repair gene expression in human ES cells 12.99
Gene profiling of human adult and pediatric liver cancer cells 12.67
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 12.5
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 12.5
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 12.5
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 12.46
Hijacking of stress response machinery by oncogenes in acute leukaemia 12.46
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 12.4
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 12.36
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 12.36
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 12.34
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 12.33
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 12.3
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 12.28
RNA Sequencing of three pairs of gastric cancer 12.27
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 12.17
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 12.16
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 12.11
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 12.08
RNA-seq of MCF10A cells and CAF 12.0
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 11.99
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 11.99
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 11.98
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 11.96
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  11.92
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 11.92
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 11.9
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 11.9
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 11.84
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 11.81
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 11.81
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 11.69
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 11.68
Reprogrammed myeloid cell transcriptomes in NSCLC 11.62
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.62
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 11.59
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 11.52
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 11.52
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 11.51
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 11.51
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 11.5
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 11.5
RNA-Seq analysis of breast cancer cells after shikonin treatment 11.47
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 11.44
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 11.39
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 11.36
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 11.36
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 11.35
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 11.33
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 11.29
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 11.26
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 11.25
RNA-seq of naive and primed ES cells (NHSM) 11.24
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 11.22
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 11.22
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 11.22
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 11.22
Generating Patterned Kidney Organoids for Studying Development and Diseases 11.16
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 11.08
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 11.08
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 11.06
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 11.05
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 11.0
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 10.97
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 10.92
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 10.86
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 10.84
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 10.83
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 10.77
RNA-seq analyisis of PUM2 knockout cells 10.6
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 10.58
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 10.56
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 10.55
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 10.54
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 10.54
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 10.51
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 10.48
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 10.42
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 10.42
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 10.42
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 10.35
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 10.35
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 10.35
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 10.34
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 10.33
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 10.17
HNF1A deficiency impairs β-cell fate, granule maturation and function 10.16
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 10.13
Toxoplasma gondii infection of human retinal pigment epithelial cells 10.08
Gene expression changes in human melanoma cell lines compared to primary melanocytes 10.07
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 10.07
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 10.06
Role of CD133 molecule in WNT response and renal repair 10.03
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 9.8
Silencing p300 in MCF7 cells to study expression and alternative splicing 9.79
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 9.77
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 9.74
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 9.67
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 9.66
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 9.64
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 9.63
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 9.63
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 9.63
Gene expression of thyroid cancer cell lines 9.61
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 9.5
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 9.5
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 9.49
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 9.49
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 9.49
Generation of KRAS signatures using immortalized isogenic lung cells. 9.47
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 9.45
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 9.42
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 9.42
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 9.41
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 9.36
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  9.3
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 9.24
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 9.24
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 9.19
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 9.13
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 9.13
Global analyses of the effect of different cellular contexts on microRNA targeting 9.13
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 9.13
An siRNA screen identifies CHD4 as a target for epigenetic therapy 9.12
Transcriptome of EBV-infected gastric cancer cell lines 9.1
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 9.08
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 9.06
Cerebellar differentiation in Ataxia-Telangiectasia 9.05
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 9.02
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 8.98
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 8.98
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 8.95
RNA-seq of stable and unstable section of human atherosclerotic plaques 8.69
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 8.61
Transcriptional responses of melanoma cells to BRAF inhibition 8.55
RNA-seq data from human lymphoma cell lines 8.52
ChIP-seq and RNA-seq from human lymphoma cell lines 8.52
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 8.52
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 8.51
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 8.5
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 8.48
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 8.42
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 8.42
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 8.41
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 8.31
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 8.24
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 8.17
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 8.17
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 8.13
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 8.04
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 8.04
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 8.03
CHD1 regulates cell fate determination by activation of differentiation-induced genes 8.01
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 7.92
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 7.92
Characterization of parental and rociletinib-resistant derived H1975 cell lines 7.84
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 7.78
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 7.75
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 7.74
RNA-seq of naive and primed ES cells 7.72
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 7.69
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 7.69
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 7.57
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 7.57
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 7.57
Hepatitis C virus functionally sequesters miR-122 7.55
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 7.55
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 7.5
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 7.34
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 7.34
An acquired vulnerability of drug resistant melanoma with therapeutic potential 7.31
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 7.31
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 7.29
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 7.26
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 7.26
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 7.23
Expression profiling of MCF-7 cells with treatment of TCDD 7.23
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 7.23
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 7.19
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 7.1
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 7.1
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 7.09
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 6.99
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 6.96
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 6.96
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 6.91
SOX11 knockdown in B-ALL cell lines 6.85
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.78
Effect of from Human Umbilical Vein Endothelial Cells 6.76
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 6.71
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 6.7
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 6.66
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 6.66
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 6.63
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 6.63
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 6.44
Analyses of T-ALL (COG study) 6.32
RNA sequencing of T-ALL (COG study) 6.32
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 6.32
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 6.18
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 6.18
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 6.17
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 6.16
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 6.16
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 6.14
Targeted enhancer activation by a subunit of the integrator complex 6.14
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 6.09
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 5.98
PTHrP overexpression in MCF7 cells 5.97
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 5.96
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 5.94
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 5.88
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 5.79
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 5.76
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 5.74
Paxillin regulates genomic networks in prostate cancer [PC3] 5.67
Interaction between mitoNEET and NAF-1 in cancer cells 5.65
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 5.61
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 5.56
STX4 Over-Expression in Human islets 5.42
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 5.42
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 5.34
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 5.26
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 5.1
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 5.04
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 5.0
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 4.98
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 4.93
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 4.93
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 4.85
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 4.85
The expression profiles of GBC liver metastasis 4.85
Gene expression profiling in metabolically heterogeneous human lung tumors 4.84
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.82
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 4.76
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 4.74
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 4.7
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 4.62
Oncogenic roles of ARID5B in T-ALL 4.59
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 4.59
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 4.58
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 4.52
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 4.51
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 4.37
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 4.33
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 4.32
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 4.31
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 4.12
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 4.12
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 4.0
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 3.93
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 3.93
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.92
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 3.78
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.75
RNA-seq differential expression studies: more sequence, or more replication? 3.73
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 3.67
Leucegene: AML sequencing (part 6) 3.58
Gene expression analysis upon mtDNA depletion 3.55
Gene expression analysis upon mtDNA depletion [RNA-seq] 3.55
Widespread regulated alternative splicing of single codons accelerates proteome evolution 3.51
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.46
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.46
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 3.44
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 3.39
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 3.25
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 3.23
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 3.19
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 3.19
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.14
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 3.11
Measure transcript integrity using RNA-seq data 3.06
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.03
Expression patterns in chronic thromboembolic pulmonary hypertension 2.98
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.95
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 2.95
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 2.89
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 2.87
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 2.87
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 2.87
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.78
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.78
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.7
Illumina Total RNA-seq in HeLa 2.67
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.63
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 2.58
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 2.58
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.57
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 2.45
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 2.45
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 2.43
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 2.33
RNAseq in Alzheimer's Disease patients 2.27
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.25
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.25
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 2.23
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 2.22
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.18
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.18
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 2.18
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.11
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 2.09
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 2.09
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 2.05
RNA expression profiles comparing primary and omental ovarian carcinoma samples 2.04
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 1.93
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.91
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 1.91
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.83
Activity-dependent transcriptional changes in human neurons 1.76
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.76
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.7
A practical evaluation of alignment algorithms for RNA variant calling analysis 1.65
Gene expression of collecting duct carcinoma of the kidney 1.58
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.57
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.54
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.54
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.53
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.53
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 1.53
Human islets of varying quality: the good, the (not so) bad and the ugly 1.39
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.39
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 1.33
Zika virus directly infects human peripheral neurons and induces cell death 1.33
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.26
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.18
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.18
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.17
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.17
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.15
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 1.12
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 1.11
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.11
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 1.1
BASP1 modifies the Tamoxifen response 1.05
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.04
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.92
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.92
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.86
Leucegene: ALL sequencing 0.78
MHC Transcriptomic landscape at haplotype-specific resolution 0.74
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 0.72
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.71
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.68
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.66
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.63
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.57
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.57
Global epigenomic reconfiguration during mammalian brain development 0.5
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.46
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.46
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.46
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.39
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.3
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.21
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.19
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.18
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.18
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.16
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.11
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.06
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.06
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation